Pathmaker Neurosystems
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1 Boston Pl Ste 2600, Boston, Massachuse...Phone Number
(617) 535-7696Website
www.pmneuro.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Pathmaker Neurosystems
PathMaker Neurosystems is a clinical-stage neuromodulation company focused on developing non-invasive devices to treat ALS and other serious neurological disorders. The company aims to commercialize innovative products that suppress neuronal hyperexcitability and activate protein degradation pathways. Utilizing multi-site direct current stimulation technology, PathMaker seeks to restore damaged neural pathways and reduce protein aggregation in motor neurons. Their approach is based on extensive pre-clinical and clinical studies, positioning them at the forefront of a new treatment paradigm for ALS.Explore more
Pathmaker Neurosystems Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pathmaker Neurosystems your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Pathmaker Neurosystems had a recent Job posting/layoffs
Product Launch: Get notified when Pathmaker Neurosystems launches new products
Check if Pathmaker Neurosystems has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Pathmaker Neurosystems has new funding data
Website visits: Recent activity has been detected on your website
Check out if Pathmaker Neurosystems is spiking on competitors!
Earning: See what the market has to say on Pathmaker Neurosystems recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Pathmaker Neurosystems
Pathmaker Neurosystems, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Pathmaker Neurosystems as Masked Content
Find 2 more new buyers
Compare Similar Companies to Pathmaker Neurosystems
Compare insights from companies similar to Pathmaker Neurosystems, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Pathmaker Neurosystems is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Pathmaker Neurosystems is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Pathmaker Neurosystems.
Pathmaker Neurosystems financials insights
Gather financial insights about Pathmaker Neurosystems, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$36K
2024
Other Financing Round
$2.2M
Pathmaker Neurosystems Tech Stack
A closer look at the technologies used by Pathmaker Neurosystems
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Facilities Relocation/Expansion, Funding, Laboratory Operations
Product Launch
Enterprise Software, Legal Affairs, Healthcare Technology
Product Launch
Enterprise Software, Legal Affairs, Healthcare Technology
Product Launch
Enterprise Software, Legal Affairs, Healthcare Technology
Executive Move
Executive Moves, Board of Directors
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pathmaker Neurosystems
Sign Up For FreeTo access detailed company insights
PathMaker Neurosystems is a clinical-stage neuromodulation company focused on developing non-invasive devices to treat ALS and other serious neurological disorders. The company aims to commercialize innovative products that suppress neuronal hyperexcitability and activate protein degradation pathways. Utilizing multi-site direct current stimulation... Read More
